Brief: Aroa Biosurgery Sees FY23 Total Revenue Guidance Maintained At NZ$62-64 Mln
30/01/2023 23:13
Jan 31 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* SEES FY23 TOTAL REVENUE GUIDANCE MAINTAINED AT NZ$62-64
MILLION
* SEES FY23 NORMALISED EBITDA EXPECTED TO BE APPROXIMATELY
BREAKEVEN
Source text for Eikon: ID:nASX7jxv4W
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million